Product NDC: | 0173-0561 |
Proprietary Name: | AMERGE |
Non Proprietary Name: | naratriptan hydrochloride |
Active Ingredient(s): | 1 mg/1 & nbsp; naratriptan hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0561 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020763 |
Marketing Category: | NDA |
Start Marketing Date: | 19980226 |
Package NDC: | 0173-0561-00 |
Package Description: | 9 TABLET, FILM COATED in 1 BLISTER PACK (0173-0561-00) |
NDC Code | 0173-0561-00 |
Proprietary Name | AMERGE |
Package Description | 9 TABLET, FILM COATED in 1 BLISTER PACK (0173-0561-00) |
Product NDC | 0173-0561 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | naratriptan hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19980226 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | NARATRIPTAN HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |